Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening. The clinical performance of three human papillomavirus (HPV) DNA commercial assays for cervical cancer screening was evaluated the AdvanSure HPV Screening Real-Time PCR (AdvanSure PCR